LDX
LUMOS FPO [LDX]
Healthcare · ASX Small Cap
$0.0800 -4.8%
Updated 21 Jul 2026 · Signals refresh every scan
Get alerts when LDX triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI is looking oversold — historically a spot where stocks tend to bounce
- MACD momentum is losing steam
- Stochastic is deep in oversold territory — bounce conditions forming
- Drifting lower — down 7.0% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.75, underperforming its peers
- Adequate cash runway (5 quarters)
- Moderate P/S ratio (6.2x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (8% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (19%)
- Sentiment is mixed — no strong consensus either way
- Beneish M-Score -1.98 (grey zone -2.22 to -1.78): possible earnings manipulation
- RBA hiking (-3pts)
- Calendar: Quarterly 4C in 9d (+5pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Broke below 20-day support — that's a level the market was defending, and it just gave way
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Deeply negative margins (-76%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 26% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-1.86%/day)
Ask Scout AI about LDX
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Q4 FY26 Results Release Date and Webinar Invitation
NONE Investor Information Sessions
NONE Notification of cessation of securities - LDX
Recent ASX Announcements
| 2026-07-20 | Q4 FY26 Results Release Date and Webinar Invitation |
| 2026-07-20 | Investor Information Sessions |
| 2026-07-14 | Notification of cessation of securities - LDX |
| 2026-07-02 | Closure of A$5M Loan Facility with Major Shareholders |
| 2026-06-28 | Lumos Receives Research & Development Tax Rebate PRICE SENSITIVE |
Key Metrics
$75.6M
Market Cap
2.5M
Avg Volume
1.1x
Vol Ratio
$0.06 — $0.33
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-123.3%
ROE
-75.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 51% |
| L | Leader vs Laggard | laggard | RS: -14 |
| I | Institutional Sponsorship | pass | Inst: 19% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
111 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track LDX and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required